Skip to search formSkip to main contentSkip to account menu

adibendan

Known as: 7,7-dimethyl-2-(4-pyridyl)-6,7-dihydro-3H,5H pyrrolo (2,3-f)benz-imidazol-6-one, Pyrrolo(2,3-f)benzimidazol-6(1H)-one, 5,7-dihydro-7,7-dimethyl-2-(4-pyridinyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Positive inotropic effects of phosphodiesterase inhibitors like 3-isobutyl-1-methylxanthine (IBMX), pimobendan, adibendan… 
1992
1992
Summary: The cardiac in vitro effects of R 80122, a novel phosphodiesterase (PDE) inhibitor, were investigated and compared with… 
1991
1989
1989
We previously reported the structure-activity relationships (SAR) of adibendan (1), a potent and long-acting cardiotonic. This… 
1989
1989
Myocardial contractile force may be altered not only by changing intracellular free Ca2+ but also by increasing or decreasing the… 
1989
1989
Several cardiotonic agents (MCI-154, sulmazole, pimobendan and adibendan) were examined for their ability to influence Ca2… 
1988
1988
1988
Summary1.The effects of adibendan (BM 14.478; 7,7-dimethyl-2-(4-pyridyl)-6,7-dihydro-3H,5H-pyrrolo[2,3-fl benzimidazole-6-one) on…